Sastasundar Ventures Ltd
HEALTHX NSE
Sastasundar Ventures Ltd
Healthcare ServicesNSE: HEALTHX BSE: 533259 Healthcare Service Provider
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcare ServicesMarket Cap
₹951 Cr
Volatility
Moderate
P/E Ratio
36.22
EBITDA
₹-53.24 Cr
Return on Equity
-15.45%
Debt to Equity
0
Book Value
₹201.47
EPS
₹11.87
52W High
₹363
52W Low
₹252.5
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sastasundar Ventures Ltd insights
46 extracted metrics + investor summaries across FY14–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company's median sales growth is 39.5% of last 10 years
- Company's working capital requirements have reduced from 66.1 days to 47.0 days
Weaknesses
2- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.66.2 Cr.
Growth Rate
Revenue Growth
12.68% ↘
Net Income Growth
-97.63% ↘
Cash Flow Change
-148.27% ↘
ROE
-2718.64% ↘
ROCE
750.91% ↗
EBITDA Margin (Avg.)
-1269.70% ↘
Quarterly Results
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 281 | 313 | 336 | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 |
| Expenses | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 |
| Operating Profit | -10.08 | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.4 | -4.72 | -23.7 | -25.2 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.59% | -3.57% | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.5% | -3% |
| Other Income | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.1 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.4 | 2.8 | 2.09 | 2.2 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| PBT | -8.74 | -5.6 | 19.03 | 10.64 | 21.01 | 5.01 | 24.64 | -174 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | -70.48% | 287.5% | -28.85% | -23.03% | 3.86% | -583.03% | -102.8% | -13.17% | 1.99% | -478.45% | 11.9% | -17.17% | 59.78% |
| Net Profit | -26.37 | -48 | -0.28 | -12.2 | -3.23 | 21.58 | 40.96 | -155 | -37.8 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -6 | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.3 | 7.52 | -3.99 | 0.36 |
Profit & Loss
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -2% | -4% |
| Other Income | 0 | 2 | 0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| PBT | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | 8 |
| Tax % | -5% | 0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | — |
| Net Profit | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9 | -3.73 | -11.81 | -12.19 | -3.27 | 197 | -22.7 | 2.79 | -28.66 | 8.19 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
Cash Flow
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Investing | -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Financing | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | 0 |
| Net Cash Flow | -10 | -1 | 0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 0 | -19 |
| Free Cash Flow | 15 | -28 | -18 | 0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 |
| CFO/OP | -845 | 106 | 43 | 17 | 377 | 89 | 133 | 288 | -8 | 104 | -172 | 68 |
Ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | — | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 |
| Days Payable | — | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% |
Documents
1
Update On Application To Stock Exchanges For Change In Name Of The Company
24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited. 24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited.
2
Approval From Stock Exchange For Change In Name And Symbol
25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026. 25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026.
3
Approval From Stock Exchange For Change In Name And Symbol
10h - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026. 10h - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026.
4
Update On Application To Stock Exchanges For Change In Name Of The Company
10h - Revised CA certificate filed to support name change to Health X Platform Limited. 10h - Revised CA certificate filed to support name change to Health X Platform Limited.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026. 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026.
Frequently Asked Questions about Sastasundar Ventures Ltd
What does Sastasundar Ventures Ltd do?
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Where is Sastasundar Ventures Ltd (HEALTHX) listed?
Sastasundar Ventures Ltd is listed on the Indian stock exchanges. It is listed on NSE: HEALTHX and BSE: 533259. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Sastasundar Ventures Ltd belong to?
Sastasundar Ventures Ltd operates in the Healthcare Services sector within the Healthcare Service Provider industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a market capitalisation of approximately ₹951.13 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Sastasundar Ventures Ltd?
The Price-to-Earnings (PE) ratio of Sastasundar Ventures Ltd is 36.22. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Sastasundar Ventures Ltd?
Over the past 52 weeks, Sastasundar Ventures Ltd has traded between a low of ₹252.5 and a high of ₹363. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a Return on Equity (ROE) of -15.45%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Sastasundar Ventures Ltd on Tapetide?
On Tapetide, you can view Sastasundar Ventures Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Website sastasundarventures.com
CEO Mr. Banwari Lal Mittal
Employees 1,657
Listed 2010-10-05
Face Value ₹ 10
Issued Size 3,18,10,500